MedPath

ACT CABERGOLINE

ACT CABERGOLINE

Dormant
DIN Number

02301407

Drug Class

Human

Market Date

Nov 6, 2007

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02301407
AIG Number0141281001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G02CB03 CABERGOLINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:36.20.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

CABERGOLINEActive
Strength: 0.5 MG
Monograph: CABERGOLINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.